We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Orchid Cellmark Awarded Forensic DNA Contracts

By Labmedica staff writers
Posted on 11 Oct 2006
Orchid Cellmark Inc., a provider of identity DNA testing services, has announced that its UK operation, Orchid Cellmark Ltd., (Abingdon, UK), has been awarded new DNA contracts with police forces in Kent, Sussex, and London.

Orchid Cellmark was awarded a three-year exclusive contract to provide DNA testing for PACE (Police and Criminal Evidence Act) and crime scene stain-profiling services for Kent and Sussex police forces. More...
There is an option to extend the contract for an additional two years. The company will also provide DNA testing services for PACE mouth swab samples for police in London. The contract is for five years.

The crime scene stain service provided to Kent and Sussex police forces involves the DNA analysis of items recovered from crimes such as burglary and car theft. There are usually no suspects in these cases and any resulting profiles are submitted to the UK National DNA Database for intelligence purposes. The shorter the time interval between the offense date and provision of intelligence from the UK National DNA Database, the greater the chance of police recovering property belonging to a complainant for offenses such as burglary.

The UK operation of Orchid Cellmark provides British customers with a full range of forensic DNA services. From the routine testing of DNA samples for submission to the National DNA Database to the collection and analysis of evidence for the investigation of the most serious crimes, Orchid Cellmark is capable of attaining results from particularly small and compromised samples. The company currently provides most of its forensic DNA services in the United Kingdom through a subcontract relationship with Forensic Alliance Ltd. This relationship is being terminated and the company is now providing its services directly to UK police forces.

Thomas Bologna, president and CEO of Orchid Cellmark Inc., commented, "We believe our DNA forensic operations in the UK are second to none in providing innovation, quality, and rapid testing turnaround time, and we are very pleased that these three important police forces have awarded contracts to Orchid Cellmark. Equally important, we believe that obtaining this business suggests that our plan to provide forensic services directly to UK police forces is proceeding well.”



Related Links:
Orchid Cellmark

New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.